Behavioral therapy to reduce nightmares in REM sleep behavior disorder

Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder

NA · University of Utah · NCT06441864

This trial will test whether a non-medication behavioral therapy delivered by videoconference can reduce frequent nightmares in adults with REM sleep behavior disorder while involving a family member.

Quick facts

PhaseNA
Study typeInterventional
Enrollment20 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Utah (other)
Locations1 site (Salt Lake City, Utah)
Trial IDNCT06441864 on ClinicalTrials.gov

What this trial studies

Adults with isolated or neurodegenerative-related REM Sleep Behavior Disorder and a cohabiting family member are enrolled and receive cognitive behavioral therapy for nightmares, including imagery rehearsal techniques, delivered via videoconference. Participants with RBD attend seven therapy sessions and their family members join two of those sessions; all participants complete two study assessments. Medications must be stable for at least one month prior to enrollment, and exclusion criteria include possible dementia, narcolepsy, PTSD, and prior behavioral nightmare treatment. The intervention aims to provide a nonpharmacologic option to reduce nightmare frequency and distress in this population.

Who should consider this trial

Good fit: Ideal candidates are English-speaking adults in the United States with isolated or secondary RBD who have nightmares at least three times per week, live with a willing family member, and have stable sleep- or neurologic-related medications.

Not a fit: Patients with possible dementia, narcolepsy, posttraumatic stress disorder, those currently in trauma- or sleep-focused psychotherapy, or those who have already received behavioral treatment for nightmares may not benefit or be eligible.

Why it matters

Potential benefit: If successful, this could provide a non-drug way to reduce nightmare frequency and distress, improve sleep safety, and lessen partner sleep disruption.

How similar studies have performed: Imagery rehearsal therapy and cognitive behavioral approaches have shown benefit for idiopathic nightmares and PTSD-related nightmares, but they have been less studied specifically in REM Sleep Behavior Disorder.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease
* Age 18 or older
* Speak, read, and write English
* Live in the United States
* Nightmare frequency ≥3 times per week
* Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder
* Sleep, neurological, and psychiatric medications stable for at least 1 month and willing to keep medications stable through the course of the study
* Live with a family member who is willing to participate in the study

Exclusion Criteria:

* Possible dementia
* Narcolepsy
* Posttraumatic stress disorder
* Previous behavioral treatment for nightmares
* Currently engaged in sleep- or trauma-focused psychotherapy
* Taking a medication that could cause RBD, if the medication was started prior to onset of RBD symptoms

Inclusion Criteria (Family Members):

* Live with a family member who meets all of the above criteria
* Age 18 or older
* Speak, read, and write English
* Live in the United States

Where this trial is running

Salt Lake City, Utah

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Nightmare, Nightmare Disorder With Associated Other Sleep Disorder, REM Sleep Behavior Disorder, Imagery Rehearsal Therapy, Cognitive Behavioral Therapy for Nightmares

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.